IkBA variant leads to EDA-ID
Hoesel B, Schmid JA. The complexity of NF-?B signaling in inflammation and cancer. Molecular Cancer. 2013 Aug 02;12(1):86. doi: 10.1186/1476-4598-12-86.; Schimke LF, Rieber N, Rylaarsdam S, Cabral-Marques O, Hubbard N, Puel A, Kallmann L, Sombke SA, Notheis G, Schwarz H, Kammer B, Hökfelt T, Repp R, Picard C, Casanova J, Belohradsky BH, Albert MH, Ochs HD, Renner ED, Torgerson TR. A Novel Gain-of-Function IKBA Mutation Underlies Ectodermal Dysplasia with Immunodeficiency and Polyendocrinopathy. Journal of Clinical Immunology. 2013 May 25;33(6):1088–99. doi: 10.1007/s10875-013-9906-1.; Lawrence T. The Nuclear Factor NF- B Pathway in Inflammation. Cold Spring Harbor Perspectives in Biology. 2009 Oct 07;1(6):a001651. doi: 10.1101/cshperspect.a001651.; Oeckinghaus A, Ghosh S. The NF- B Family of Transcription Factors and Its Regulation. Cold Spring Harbor Perspectives in Biology. 2009 Sep 02;1(4):a000034. doi: 10.1101/cshperspect.a000034.; Lopez-Granados E, Keenan JE, Kinney MC, Leo H, Jain N, Ma CA, Quinones R, Gelfand EW, Jain A. A novel mutation in NFKBIA/IKBA results in a degradation-resistant N-truncated protein and is associated with ectodermal dysplasia with immunodeficiency. Hum Mutat. 2008 Jun;29(6):861–8. PMID: 18412279; PMCID: PMC3179847.; Courtois G, Smahi A, Reichenbach J, Döffinger R, Cancrini C, Bonnet M, Puel A, Chable-Bessia C, Yamaoka S, Feinberg J, Dupuis-Girod S, Bodemer C, Livadiotti S, Novelli F, Rossi P, Fischer A, Israël A, Munnich A, Le Deist F, Casanova JL. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest. 2003 Oct;112(7):1108–15. PMID: 14523047; PMCID: PMC198529.; Scherer DC, Brockman JA, Chen Z, Maniatis T, Ballard DW. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc. Natl. Acad. Sci. U.S.A. 1995 Nov 21;92(24):11259–63. doi: 10.1073/pnas.92.24.11259.; Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A, Ben-Neriah Y. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. U.S.A. 1995 Nov 07;92(23):10599–603. doi: 10.1073/pnas.92.23.10599.